Opus advises Synthomer Plc on its divestment of William Blythe Ltd to its management team and H2 Equity Partners

Category: Company Update

Opus is delighted to have advised Synthomer Plc on its divestment of William Blythe Ltd to its management team and H2 Equity Partners, for £30m.

Founded in 1845, William Blythe has pioneered the development and use of inorganic derivatives of elements such as tin, iodine, copper, zinc and tungsten for demanding applications in markets including life sciences, performance coatings, polymers, electronics, catalysts and renewable energy for 180 years.

The transaction is expected to complete at the end of May 2025.

For further information please contact: Chris Carlisle, Daniel Barley, Ed Batchelor.